Ignite Creation Date:
2024-05-05 @ 6:39 PM
Last Modification Date:
2024-10-26 @ 9:36 AM
Study NCT ID:
NCT00525746
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2020-01-14
First Post:
2007-09-04
Brief Title:
Molecular Epidemiology of Therapy-related Acute Myeloid LeukemiaMyelodysplastic Syndrome AMLMDS
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Study Overview
Official Title:
Molecular Epidemiology of Treatment-Related Acute Myeloid LeukemiaMyelodysplastic Syndrome
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2020-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this research study is to identify biologic and lifestyle factors that may increase a persons risk of developing acute myeloid leukemia or myelodysplastic syndrome after treatment for a previous cancer treatment-related AMLMDS
Detailed Description:
For this study you will be asked to take part in a personal or mail interview During the interview you will be asked questions about your demographics age sex etc any chemicals you may have been exposed to your medical history family history of cancer your diet and your smoking and alcohol use histories It should take around 50 minutes to complete the interview Treatment information from your medical records at M D Anderson will also be collected
You will be asked to provide a saliva sample or have around 1 tablespoon of blood drawn for special tests These tests will look for biologic factors associated with treatment-related AMLMDS
Your participation in this study will be over once the interview has been completed and blood or saliva have been collected
This is an investigational study Up to 600 participants will take part in this study All will be enrolled at M D Anderson
You will be asked to provide a saliva sample or have around 1 tablespoon of blood drawn for special tests These tests will look for biologic factors associated with treatment-related AMLMDS
Your participation in this study will be over once the interview has been completed and blood or saliva have been collected
This is an investigational study Up to 600 participants will take part in this study All will be enrolled at M D Anderson
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None